NOT:ETR
Novartis AG
145,66 €
arrow_downward
−0,74%(−1,08) 1 p
6. nov, 17:35:44 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOT põhistatistika genereerimine…
Ava
143,24 €
Kõrge
145,66 €
Madal
142,26 €
Turu kapit.
335,52Â mld
Keskm. maht
5,49Â tuh
Maht
3,31Â tuh
52 näd kõrgeim
147,88 €
52 näd madalaim
107,00 €
Töötajate arv
75Â tuh
Ava
143,24 €
Kõrge
145,66 €
Madal
142,26 €
Turu kapit.
335,52Â mld
Keskm. maht
5,49Â tuh
Maht
3,31Â tuh
52 näd kõrgeim
147,88 €
52 näd madalaim
107,00 €
Töötajate arv
75Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Seeking Alpha
·
1 päeva eest
Novartis stock slips amid Zolgensma safety concerns (NVS:NYSE)
Yahoo Finance
·
3 päeva eest
Novartis: 3 Key Takeaways for Long-Term Investors
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Å veits
SektorHealth Care
Valdkond-
Veebisaitnovartis.com